Mitotic arrest-induced phosphorylation of Mcl-1 revisited using two-dimensional gel electrophoresis and phosphoproteomics: nine phosphorylation sites identified.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27738316)

Published in Oncotarget on October 12, 2016

Authors

Rong Chu1, Sarah E Alford1, Katherine Hart1, Anisha Kothari1, Samuel G Mackintosh1, Matthew R Kovak1, Timothy C Chambers1

Author Affiliations

1: Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

Articles cited by this

The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell (2006) 10.19

Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell (2006) 8.59

Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell (2006) 7.18

Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev (2003) 6.17

Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature (2011) 5.32

Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation. Cancer Res (2007) 3.92

Mcl-1; the molecular regulation of protein function. FEBS Lett (2010) 2.71

MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol. Oncogene (2004) 2.62

Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest. EMBO J (2010) 2.33

Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell Mol Life Sci (2009) 2.31

Unique biology of Mcl-1: therapeutic opportunities in cancer. Curr Mol Med (2008) 2.22

Cyclin-dependent kinase 1-mediated Bcl-xL/Bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis. Mol Cell Biol (2009) 1.74

Serine 64 phosphorylation enhances the antiapoptotic function of Mcl-1. J Biol Chem (2007) 1.63

Delving deeper: MCL-1's contributions to normal and cancer biology. Trends Cell Biol (2012) 1.60

Mcl-1 integrates the opposing actions of signaling pathways that mediate survival and apoptosis. Mol Cell Biol (2009) 1.56

Ubiquitin-independent degradation of antiapoptotic MCL-1. Mol Cell Biol (2010) 1.54

Identification of the major phosphorylation site in Bcl-xL induced by microtubule inhibitors and analysis of its functional significance. J Biol Chem (2008) 1.46

Characterization of vinblastine-induced Bcl-xL and Bcl-2 phosphorylation: evidence for a novel protein kinase and a coordinated phosphorylation/dephosphorylation cycle associated with apoptosis induction. Oncogene (2005) 1.30

Mcl-1 stability determines mitotic cell fate of human multiple myeloma tumor cells treated with the kinesin spindle protein inhibitor ARRY-520. Mol Cancer Ther (2010) 1.14

Cyclin-dependent kinase-1 (Cdk1)/cyclin B1 dictates cell fate after mitotic arrest via phosphoregulation of antiapoptotic Bcl-2 proteins. J Biol Chem (2012) 1.13

Improved protein solubility in two-dimensional electrophoresis using tributyl phosphine as reducing agent. Electrophoresis (1998) 1.11

Modulation of mitogen-activated protein kinases and phosphorylation of Bcl-2 by vinblastine represent persistent forms of normal fluctuations at G2-M1. Cancer Res (2000) 1.10

Vinblastine-induced apoptosis is mediated by discrete alterations in subcellular location, oligomeric structure, and activation status of specific Bcl-2 family members. J Biol Chem (2006) 1.03

Key role for Bak activation and Bak-Bax interaction in the apoptotic response to vinblastine. Mol Cancer Ther (2008) 1.00

Cdk1/cyclin B plays a key role in mitotic arrest-induced apoptosis by phosphorylation of Mcl-1, promoting its degradation and freeing Bak from sequestration. Biochem Pharmacol (2011) 1.00

Critical role of anti-apoptotic Bcl-2 protein phosphorylation in mitotic death. Cell Death Dis (2013) 0.99

Molecular analysis of functional redundancy among anti-apoptotic Bcl-2 proteins and its role in cancer cell survival. Exp Cell Res (2014) 0.96

Cyclin E/Cdk2-dependent phosphorylation of Mcl-1 determines its stability and cellular sensitivity to BH3 mimetics. Oncotarget (2015) 0.92

BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells. Cancer Res (2015) 0.91

MCL1 meets its end during mitotic arrest. EMBO Rep (2011) 0.89

Destruction's our delight: controlling apoptosis during mitotic arrest. Cell Cycle (2010) 0.87

Identification of a mitotic death signature in cancer cell lines. Cancer Lett (2013) 0.84

Serine 162, an essential residue for the mitochondrial localization, stability and anti-apoptotic function of Mcl-1. PLoS One (2012) 0.82